nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—type 2 diabetes mellitus	0.419	1	CbGaD
Levetiracetam—ABCC2—Glyburide—type 2 diabetes mellitus	0.0633	0.219	CbGbCtD
Levetiracetam—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0625	0.216	CbGbCtD
Levetiracetam—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0557	0.193	CbGbCtD
Levetiracetam—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0403	0.139	CbGbCtD
Levetiracetam—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0277	0.0958	CbGbCtD
Levetiracetam—ABCB1—Glyburide—type 2 diabetes mellitus	0.0206	0.0714	CbGbCtD
Levetiracetam—ABCB1—Losartan—type 2 diabetes mellitus	0.0189	0.0653	CbGbCtD
Levetiracetam—SV2A—Disease—TLE4—type 2 diabetes mellitus	0.000221	0.00256	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	0.000216	0.0025	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HK1—type 2 diabetes mellitus	0.000213	0.00246	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000211	0.00244	CbGpPWpGaD
Levetiracetam—SV2A—Disease—GCKR—type 2 diabetes mellitus	0.000205	0.00238	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—ADCY5—type 2 diabetes mellitus	0.0002	0.00232	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ALDOB—type 2 diabetes mellitus	0.000197	0.00228	CbGpPWpGaD
Levetiracetam—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—type 2 diabetes mellitus	0.000189	0.00219	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SPRY2—type 2 diabetes mellitus	0.000188	0.00217	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	0.000187	0.00216	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—type 2 diabetes mellitus	0.000185	0.00214	CbGpPWpGaD
Levetiracetam—SV2A—Disease—RBP4—type 2 diabetes mellitus	0.000183	0.00212	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—type 2 diabetes mellitus	0.00018	0.00209	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—HK1—type 2 diabetes mellitus	0.000175	0.00202	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—CALM1—type 2 diabetes mellitus	0.000172	0.00199	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SLC2A2—type 2 diabetes mellitus	0.000171	0.00198	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MTR—type 2 diabetes mellitus	0.000167	0.00194	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NAMPT—type 2 diabetes mellitus	0.000164	0.0019	CbGpPWpGaD
Levetiracetam—SV2A—Disease—GCK—type 2 diabetes mellitus	0.000163	0.00189	CbGpPWpGaD
Levetiracetam—SV2A—Disease—IAPP—type 2 diabetes mellitus	0.000162	0.00188	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000162	0.00187	CbGpPWpGaD
Levetiracetam—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	0.00016	0.00186	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SLC9A1—type 2 diabetes mellitus	0.000159	0.00184	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—SLC2A2—type 2 diabetes mellitus	0.000158	0.00183	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HMGA1—type 2 diabetes mellitus	0.000149	0.00173	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000147	0.0017	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SNAP25—type 2 diabetes mellitus	0.000146	0.00169	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PSMD6—type 2 diabetes mellitus	0.000146	0.00169	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CYBA—type 2 diabetes mellitus	0.000142	0.00164	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—HNF4A—type 2 diabetes mellitus	0.000138	0.00159	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CALCA—type 2 diabetes mellitus	0.000137	0.00159	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—GCK—type 2 diabetes mellitus	0.000134	0.00155	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SLC2A1—type 2 diabetes mellitus	0.000132	0.00153	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOS1—type 2 diabetes mellitus	0.00013	0.00151	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TCF7L2—type 2 diabetes mellitus	0.000129	0.00149	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SLC2A4—type 2 diabetes mellitus	0.000127	0.00147	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	0.000123	0.00142	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—SLC2A1—type 2 diabetes mellitus	0.000123	0.00142	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—SLC2A4—type 2 diabetes mellitus	0.000117	0.00136	CbGpPWpGaD
Levetiracetam—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000115	0.00056	CcSEcCtD
Levetiracetam—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000115	0.00056	CcSEcCtD
Levetiracetam—Agitation—Irbesartan—type 2 diabetes mellitus	0.000115	0.000559	CcSEcCtD
Levetiracetam—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000115	0.000559	CcSEcCtD
Levetiracetam—Nervousness—Losartan—type 2 diabetes mellitus	0.000114	0.000556	CcSEcCtD
Levetiracetam—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000114	0.000554	CcSEcCtD
Levetiracetam—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000114	0.000554	CcSEcCtD
Levetiracetam—Back pain—Losartan—type 2 diabetes mellitus	0.000114	0.000554	CcSEcCtD
Levetiracetam—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000114	0.000554	CcSEcCtD
Levetiracetam—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000114	0.000553	CcSEcCtD
Levetiracetam—Anorexia—Valsartan—type 2 diabetes mellitus	0.000113	0.000551	CcSEcCtD
Levetiracetam—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000113	0.00055	CcSEcCtD
Levetiracetam—Chest pain—Metformin—type 2 diabetes mellitus	0.000113	0.000549	CcSEcCtD
Levetiracetam—Myalgia—Metformin—type 2 diabetes mellitus	0.000113	0.000549	CcSEcCtD
Levetiracetam—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000112	0.000547	CcSEcCtD
Levetiracetam—Headache—Pioglitazone—type 2 diabetes mellitus	0.000112	0.000546	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000112	0.000545	CcSEcCtD
Levetiracetam—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000112	0.000544	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000112	0.000543	CcSEcCtD
Levetiracetam—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000111	0.000542	CcSEcCtD
Levetiracetam—Nausea—Glipizide—type 2 diabetes mellitus	0.000111	0.00054	CcSEcCtD
Levetiracetam—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000111	0.00054	CcSEcCtD
Levetiracetam—Vision blurred—Losartan—type 2 diabetes mellitus	0.000111	0.00054	CcSEcCtD
Levetiracetam—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000111	0.000538	CcSEcCtD
Levetiracetam—Constipation—Gliclazide—type 2 diabetes mellitus	0.000111	0.000538	CcSEcCtD
Levetiracetam—Pain—Gliclazide—type 2 diabetes mellitus	0.000111	0.000538	CcSEcCtD
Levetiracetam—SV2A—Disease—TGFBR2—type 2 diabetes mellitus	0.00011	0.00128	CbGpPWpGaD
Levetiracetam—Tremor—Losartan—type 2 diabetes mellitus	0.00011	0.000536	CcSEcCtD
Levetiracetam—ABCB1—ABC-family proteins mediated transport—APOA1—type 2 diabetes mellitus	0.00011	0.00127	CbGpPWpGaD
Levetiracetam—Rash—Glimepiride—type 2 diabetes mellitus	0.00011	0.000535	CcSEcCtD
Levetiracetam—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00011	0.000535	CcSEcCtD
Levetiracetam—Rash—Sitagliptin—type 2 diabetes mellitus	0.00011	0.000534	CcSEcCtD
Levetiracetam—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00011	0.000533	CcSEcCtD
Levetiracetam—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.00011	0.000533	CcSEcCtD
Levetiracetam—Headache—Glimepiride—type 2 diabetes mellitus	0.000109	0.000532	CcSEcCtD
Levetiracetam—Cough—Irbesartan—type 2 diabetes mellitus	0.000109	0.000531	CcSEcCtD
Levetiracetam—Headache—Sitagliptin—type 2 diabetes mellitus	0.000109	0.00053	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—type 2 diabetes mellitus	0.000109	0.00126	CbGpPWpGaD
Levetiracetam—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000108	0.000526	CcSEcCtD
Levetiracetam—Agitation—Losartan—type 2 diabetes mellitus	0.000108	0.000526	CcSEcCtD
Levetiracetam—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000108	0.000524	CcSEcCtD
Levetiracetam—Infection—Metformin—type 2 diabetes mellitus	0.000107	0.000523	CcSEcCtD
Levetiracetam—Insomnia—Valsartan—type 2 diabetes mellitus	0.000107	0.000522	CcSEcCtD
Levetiracetam—SV2A—Disease—CDKN2B—type 2 diabetes mellitus	0.000107	0.00124	CbGpPWpGaD
Levetiracetam—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000107	0.00052	CcSEcCtD
Levetiracetam—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000107	0.000519	CcSEcCtD
Levetiracetam—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000106	0.000518	CcSEcCtD
Levetiracetam—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000106	0.000518	CcSEcCtD
Levetiracetam—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000106	0.000518	CcSEcCtD
Levetiracetam—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000106	0.000518	CcSEcCtD
Levetiracetam—Insomnia—Orlistat—type 2 diabetes mellitus	0.000106	0.000516	CcSEcCtD
Levetiracetam—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000106	0.000516	CcSEcCtD
Levetiracetam—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000106	0.000516	CcSEcCtD
Levetiracetam—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000106	0.000516	CcSEcCtD
Levetiracetam—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000106	0.000515	CcSEcCtD
Levetiracetam—Vertigo—Losartan—type 2 diabetes mellitus	0.000106	0.000514	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000106	0.000514	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000106	0.000514	CcSEcCtD
Levetiracetam—Somnolence—Valsartan—type 2 diabetes mellitus	0.000106	0.000514	CcSEcCtD
Levetiracetam—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000105	0.000513	CcSEcCtD
Levetiracetam—Leukopenia—Losartan—type 2 diabetes mellitus	0.000105	0.000512	CcSEcCtD
Levetiracetam—Skin disorder—Metformin—type 2 diabetes mellitus	0.000105	0.000511	CcSEcCtD
Levetiracetam—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000105	0.000509	CcSEcCtD
Levetiracetam—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000105	0.000509	CcSEcCtD
Levetiracetam—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000104	0.000508	CcSEcCtD
Levetiracetam—SV2A—Disease—APOB—type 2 diabetes mellitus	0.000104	0.00121	CbGpPWpGaD
Levetiracetam—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000507	CcSEcCtD
Levetiracetam—Nausea—Glimepiride—type 2 diabetes mellitus	0.000104	0.000504	CcSEcCtD
Levetiracetam—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000103	0.000503	CcSEcCtD
Levetiracetam—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000103	0.000502	CcSEcCtD
Levetiracetam—Asthenia—Glyburide—type 2 diabetes mellitus	0.000103	0.000502	CcSEcCtD
Levetiracetam—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000103	0.000502	CcSEcCtD
Levetiracetam—Anorexia—Metformin—type 2 diabetes mellitus	0.000103	0.000501	CcSEcCtD
Levetiracetam—Cough—Losartan—type 2 diabetes mellitus	0.000103	0.0005	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000103	0.000499	CcSEcCtD
Levetiracetam—Alopecia—Ramipril—type 2 diabetes mellitus	0.000102	0.000498	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—type 2 diabetes mellitus	0.000102	0.00118	CbGpPWpGaD
Levetiracetam—Fatigue—Valsartan—type 2 diabetes mellitus	0.000102	0.000498	CcSEcCtD
Levetiracetam—ABCC2—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	0.000102	0.00118	CbGpPWpGaD
Levetiracetam—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000102	0.000497	CcSEcCtD
Levetiracetam—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000102	0.000497	CcSEcCtD
Levetiracetam—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000102	0.000496	CcSEcCtD
Levetiracetam—Pruritus—Glyburide—type 2 diabetes mellitus	0.000102	0.000495	CcSEcCtD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	0.000102	0.00118	CbGpPWpGaD
Levetiracetam—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000102	0.000494	CcSEcCtD
Levetiracetam—Constipation—Valsartan—type 2 diabetes mellitus	0.000102	0.000494	CcSEcCtD
Levetiracetam—Infection—Irbesartan—type 2 diabetes mellitus	0.000101	0.000493	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000101	0.000493	CcSEcCtD
Levetiracetam—Fatigue—Orlistat—type 2 diabetes mellitus	0.000101	0.000492	CcSEcCtD
Levetiracetam—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000101	0.000491	CcSEcCtD
Levetiracetam—ABCC2—NRF2 pathway—HMOX1—type 2 diabetes mellitus	0.000101	0.00117	CbGpPWpGaD
Levetiracetam—Pain—Orlistat—type 2 diabetes mellitus	0.0001	0.000488	CcSEcCtD
Levetiracetam—Arthralgia—Losartan—type 2 diabetes mellitus	0.0001	0.000487	CcSEcCtD
Levetiracetam—Myalgia—Losartan—type 2 diabetes mellitus	0.0001	0.000487	CcSEcCtD
Levetiracetam—Chest pain—Losartan—type 2 diabetes mellitus	0.0001	0.000487	CcSEcCtD
Levetiracetam—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.0001	0.000487	CcSEcCtD
Levetiracetam—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.0001	0.000487	CcSEcCtD
Levetiracetam—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.99e-05	0.000486	CcSEcCtD
Levetiracetam—Anxiety—Losartan—type 2 diabetes mellitus	9.98e-05	0.000486	CcSEcCtD
Levetiracetam—SV2A—Disease—LPL—type 2 diabetes mellitus	9.96e-05	0.00115	CbGpPWpGaD
Levetiracetam—Rash—Bromocriptine—type 2 diabetes mellitus	9.93e-05	0.000483	CcSEcCtD
Levetiracetam—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.92e-05	0.000483	CcSEcCtD
Levetiracetam—Skin disorder—Irbesartan—type 2 diabetes mellitus	9.91e-05	0.000482	CcSEcCtD
Levetiracetam—Tension—Ramipril—type 2 diabetes mellitus	9.9e-05	0.000482	CcSEcCtD
Levetiracetam—Headache—Bromocriptine—type 2 diabetes mellitus	9.86e-05	0.00048	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	9.85e-05	0.000479	CcSEcCtD
Levetiracetam—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.85e-05	0.000479	CcSEcCtD
Levetiracetam—Nervousness—Ramipril—type 2 diabetes mellitus	9.8e-05	0.000477	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	9.79e-05	0.00113	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ADCY5—type 2 diabetes mellitus	9.75e-05	0.00113	CbGpPWpGaD
Levetiracetam—Anorexia—Irbesartan—type 2 diabetes mellitus	9.73e-05	0.000473	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.71e-05	0.000472	CcSEcCtD
Levetiracetam—Paraesthesia—Metformin—type 2 diabetes mellitus	9.71e-05	0.000472	CcSEcCtD
Levetiracetam—Confusional state—Losartan—type 2 diabetes mellitus	9.68e-05	0.000471	CcSEcCtD
Levetiracetam—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.67e-05	0.00047	CcSEcCtD
Levetiracetam—Somnolence—Metformin—type 2 diabetes mellitus	9.61e-05	0.000468	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.59e-05	0.000467	CcSEcCtD
Levetiracetam—Infection—Losartan—type 2 diabetes mellitus	9.54e-05	0.000464	CcSEcCtD
Levetiracetam—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.52e-05	0.000463	CcSEcCtD
Levetiracetam—Dyspepsia—Metformin—type 2 diabetes mellitus	9.52e-05	0.000463	CcSEcCtD
Levetiracetam—Tremor—Ramipril—type 2 diabetes mellitus	9.45e-05	0.00046	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	9.45e-05	0.00109	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	9.45e-05	0.00109	CbGpPWpGaD
Levetiracetam—Nervous system disorder—Losartan—type 2 diabetes mellitus	9.42e-05	0.000458	CcSEcCtD
Levetiracetam—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.4e-05	0.000457	CcSEcCtD
Levetiracetam—Decreased appetite—Metformin—type 2 diabetes mellitus	9.4e-05	0.000457	CcSEcCtD
Levetiracetam—ABCC2—NRF2 pathway—GSTM1—type 2 diabetes mellitus	9.39e-05	0.00109	CbGpPWpGaD
Levetiracetam—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.39e-05	0.000457	CcSEcCtD
Levetiracetam—Nausea—Bromocriptine—type 2 diabetes mellitus	9.35e-05	0.000455	CcSEcCtD
Levetiracetam—SV2A—Disease—PPP2CA—type 2 diabetes mellitus	9.34e-05	0.00108	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.33e-05	0.000454	CcSEcCtD
Levetiracetam—Fatigue—Metformin—type 2 diabetes mellitus	9.32e-05	0.000454	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	9.3e-05	0.000452	CcSEcCtD
Levetiracetam—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.27e-05	0.000451	CcSEcCtD
Levetiracetam—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.27e-05	0.000451	CcSEcCtD
Levetiracetam—Asthenia—Gliclazide—type 2 diabetes mellitus	9.27e-05	0.000451	CcSEcCtD
Levetiracetam—Agitation—Ramipril—type 2 diabetes mellitus	9.27e-05	0.000451	CcSEcCtD
Levetiracetam—Constipation—Metformin—type 2 diabetes mellitus	9.25e-05	0.00045	CcSEcCtD
Levetiracetam—SV2A—Disease—CCR5—type 2 diabetes mellitus	9.18e-05	0.00106	CbGpPWpGaD
Levetiracetam—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.16e-05	0.000446	CcSEcCtD
Levetiracetam—Anorexia—Losartan—type 2 diabetes mellitus	9.15e-05	0.000445	CcSEcCtD
Levetiracetam—Vomiting—Glyburide—type 2 diabetes mellitus	9.15e-05	0.000445	CcSEcCtD
Levetiracetam—Pruritus—Gliclazide—type 2 diabetes mellitus	9.14e-05	0.000445	CcSEcCtD
Levetiracetam—Rash—Glyburide—type 2 diabetes mellitus	9.07e-05	0.000442	CcSEcCtD
Levetiracetam—Somnolence—Irbesartan—type 2 diabetes mellitus	9.07e-05	0.000441	CcSEcCtD
Levetiracetam—Dermatitis—Glyburide—type 2 diabetes mellitus	9.07e-05	0.000441	CcSEcCtD
Levetiracetam—Vertigo—Ramipril—type 2 diabetes mellitus	9.06e-05	0.000441	CcSEcCtD
Levetiracetam—ABCC2—NRF2 pathway—AGER—type 2 diabetes mellitus	9.06e-05	0.00105	CbGpPWpGaD
Levetiracetam—Leukopenia—Ramipril—type 2 diabetes mellitus	9.03e-05	0.000439	CcSEcCtD
Levetiracetam—Headache—Glyburide—type 2 diabetes mellitus	9.02e-05	0.000439	CcSEcCtD
Levetiracetam—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.98e-05	0.000437	CcSEcCtD
Levetiracetam—SV2A—Disease—MTHFR—type 2 diabetes mellitus	8.97e-05	0.00104	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—HMOX1—type 2 diabetes mellitus	8.94e-05	0.00104	CbGpPWpGaD
Levetiracetam—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.91e-05	0.000434	CcSEcCtD
Levetiracetam—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.87e-05	0.000432	CcSEcCtD
Levetiracetam—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.84e-05	0.00043	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.84e-05	0.00043	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	8.81e-05	0.000429	CcSEcCtD
Levetiracetam—Cough—Ramipril—type 2 diabetes mellitus	8.8e-05	0.000428	CcSEcCtD
Levetiracetam—Fatigue—Irbesartan—type 2 diabetes mellitus	8.8e-05	0.000428	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.75e-05	0.000426	CcSEcCtD
Levetiracetam—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.75e-05	0.000426	CcSEcCtD
Levetiracetam—Convulsion—Ramipril—type 2 diabetes mellitus	8.74e-05	0.000425	CcSEcCtD
Levetiracetam—Constipation—Irbesartan—type 2 diabetes mellitus	8.73e-05	0.000425	CcSEcCtD
Levetiracetam—Pain—Irbesartan—type 2 diabetes mellitus	8.73e-05	0.000425	CcSEcCtD
Levetiracetam—Insomnia—Losartan—type 2 diabetes mellitus	8.69e-05	0.000423	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	8.64e-05	0.001	CbGpPWpGaD
Levetiracetam—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.64e-05	0.000421	CcSEcCtD
Levetiracetam—Paraesthesia—Losartan—type 2 diabetes mellitus	8.62e-05	0.00042	CcSEcCtD
Levetiracetam—Arthralgia—Ramipril—type 2 diabetes mellitus	8.59e-05	0.000418	CcSEcCtD
Levetiracetam—Chest pain—Ramipril—type 2 diabetes mellitus	8.59e-05	0.000418	CcSEcCtD
Levetiracetam—Myalgia—Ramipril—type 2 diabetes mellitus	8.59e-05	0.000418	CcSEcCtD
Levetiracetam—Anxiety—Ramipril—type 2 diabetes mellitus	8.56e-05	0.000416	CcSEcCtD
Levetiracetam—SV2A—Disease—HIF1A—type 2 diabetes mellitus	8.55e-05	0.00099	CbGpPWpGaD
Levetiracetam—Nausea—Glyburide—type 2 diabetes mellitus	8.55e-05	0.000416	CcSEcCtD
Levetiracetam—Abdominal pain—Metformin—type 2 diabetes mellitus	8.55e-05	0.000416	CcSEcCtD
Levetiracetam—Dizziness—Gliclazide—type 2 diabetes mellitus	8.55e-05	0.000416	CcSEcCtD
Levetiracetam—Somnolence—Losartan—type 2 diabetes mellitus	8.54e-05	0.000415	CcSEcCtD
Levetiracetam—SV2A—Disease—IRS2—type 2 diabetes mellitus	8.53e-05	0.000987	CbGpPWpGaD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	8.53e-05	0.000415	CcSEcCtD
Levetiracetam—Asthenia—Valsartan—type 2 diabetes mellitus	8.52e-05	0.000414	CcSEcCtD
Levetiracetam—Dyspepsia—Losartan—type 2 diabetes mellitus	8.45e-05	0.000411	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—EDN1—type 2 diabetes mellitus	8.43e-05	0.000976	CbGpPWpGaD
Levetiracetam—Asthenia—Orlistat—type 2 diabetes mellitus	8.42e-05	0.00041	CcSEcCtD
Levetiracetam—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.41e-05	0.000409	CcSEcCtD
Levetiracetam—Pruritus—Valsartan—type 2 diabetes mellitus	8.4e-05	0.000409	CcSEcCtD
Levetiracetam—SV2A—Disease—CALM1—type 2 diabetes mellitus	8.38e-05	0.00097	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APOE—type 2 diabetes mellitus	8.35e-05	0.000966	CbGpPWpGaD
Levetiracetam—Decreased appetite—Losartan—type 2 diabetes mellitus	8.35e-05	0.000406	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.34e-05	0.000406	CcSEcCtD
Levetiracetam—Confusional state—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000404	CcSEcCtD
Levetiracetam—Pruritus—Orlistat—type 2 diabetes mellitus	8.3e-05	0.000404	CcSEcCtD
Levetiracetam—Fatigue—Losartan—type 2 diabetes mellitus	8.28e-05	0.000403	CcSEcCtD
Levetiracetam—SV2A—Disease—APOA1—type 2 diabetes mellitus	8.25e-05	0.000955	CbGpPWpGaD
Levetiracetam—Vomiting—Gliclazide—type 2 diabetes mellitus	8.22e-05	0.0004	CcSEcCtD
Levetiracetam—Pain—Losartan—type 2 diabetes mellitus	8.21e-05	0.0004	CcSEcCtD
Levetiracetam—Constipation—Losartan—type 2 diabetes mellitus	8.21e-05	0.0004	CcSEcCtD
Levetiracetam—Rash—Gliclazide—type 2 diabetes mellitus	8.15e-05	0.000396	CcSEcCtD
Levetiracetam—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.14e-05	0.000396	CcSEcCtD
Levetiracetam—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.12e-05	0.000395	CcSEcCtD
Levetiracetam—Headache—Gliclazide—type 2 diabetes mellitus	8.1e-05	0.000394	CcSEcCtD
Levetiracetam—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.07e-05	0.000393	CcSEcCtD
Levetiracetam—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.07e-05	0.000392	CcSEcCtD
Levetiracetam—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.07e-05	0.000392	CcSEcCtD
Levetiracetam—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.06e-05	0.000392	CcSEcCtD
Levetiracetam—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.03e-05	0.000391	CcSEcCtD
Levetiracetam—Skin disorder—Ramipril—type 2 diabetes mellitus	8e-05	0.000389	CcSEcCtD
Levetiracetam—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.91e-05	0.000385	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.85e-05	0.000382	CcSEcCtD
Levetiracetam—Dizziness—Valsartan—type 2 diabetes mellitus	7.85e-05	0.000382	CcSEcCtD
Levetiracetam—Anorexia—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000382	CcSEcCtD
Levetiracetam—SV2A—Disease—NOS2—type 2 diabetes mellitus	7.78e-05	0.0009	CbGpPWpGaD
Levetiracetam—Dizziness—Orlistat—type 2 diabetes mellitus	7.76e-05	0.000377	CcSEcCtD
Levetiracetam—Asthenia—Metformin—type 2 diabetes mellitus	7.76e-05	0.000377	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	7.7e-05	0.000892	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	7.7e-05	0.000892	CbGpPWpGaD
Levetiracetam—Nausea—Gliclazide—type 2 diabetes mellitus	7.68e-05	0.000373	CcSEcCtD
Levetiracetam—Pruritus—Metformin—type 2 diabetes mellitus	7.65e-05	0.000372	CcSEcCtD
Levetiracetam—Body temperature increased—Losartan—type 2 diabetes mellitus	7.59e-05	0.000369	CcSEcCtD
Levetiracetam—Abdominal pain—Losartan—type 2 diabetes mellitus	7.59e-05	0.000369	CcSEcCtD
Levetiracetam—Vomiting—Valsartan—type 2 diabetes mellitus	7.55e-05	0.000367	CcSEcCtD
Levetiracetam—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.52e-05	0.000366	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.5e-05	0.000365	CcSEcCtD
Levetiracetam—Rash—Valsartan—type 2 diabetes mellitus	7.49e-05	0.000364	CcSEcCtD
Levetiracetam—Dermatitis—Valsartan—type 2 diabetes mellitus	7.48e-05	0.000364	CcSEcCtD
Levetiracetam—Vomiting—Orlistat—type 2 diabetes mellitus	7.46e-05	0.000363	CcSEcCtD
Levetiracetam—SV2A—Disease—IRS1—type 2 diabetes mellitus	7.45e-05	0.000862	CbGpPWpGaD
Levetiracetam—Insomnia—Ramipril—type 2 diabetes mellitus	7.45e-05	0.000362	CcSEcCtD
Levetiracetam—Headache—Valsartan—type 2 diabetes mellitus	7.44e-05	0.000362	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	7.42e-05	0.000858	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	7.42e-05	0.000858	CbGpPWpGaD
Levetiracetam—Diarrhoea—Metformin—type 2 diabetes mellitus	7.4e-05	0.00036	CcSEcCtD
Levetiracetam—Rash—Orlistat—type 2 diabetes mellitus	7.4e-05	0.00036	CcSEcCtD
Levetiracetam—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.39e-05	0.00036	CcSEcCtD
Levetiracetam—Dermatitis—Orlistat—type 2 diabetes mellitus	7.39e-05	0.00036	CcSEcCtD
Levetiracetam—Headache—Orlistat—type 2 diabetes mellitus	7.35e-05	0.000358	CcSEcCtD
Levetiracetam—Asthenia—Irbesartan—type 2 diabetes mellitus	7.32e-05	0.000356	CcSEcCtD
Levetiracetam—Somnolence—Ramipril—type 2 diabetes mellitus	7.32e-05	0.000356	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	7.29e-05	0.000843	CbGpPWpGaD
Levetiracetam—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000353	CcSEcCtD
Levetiracetam—Pruritus—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000351	CcSEcCtD
Levetiracetam—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.16e-05	0.000348	CcSEcCtD
Levetiracetam—Dizziness—Metformin—type 2 diabetes mellitus	7.15e-05	0.000348	CcSEcCtD
Levetiracetam—SV2A—Disease—INS—type 2 diabetes mellitus	7.13e-05	0.000825	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000346	CcSEcCtD
Levetiracetam—Fatigue—Ramipril—type 2 diabetes mellitus	7.1e-05	0.000345	CcSEcCtD
Levetiracetam—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.07e-05	0.000344	CcSEcCtD
Levetiracetam—Nausea—Valsartan—type 2 diabetes mellitus	7.05e-05	0.000343	CcSEcCtD
Levetiracetam—Constipation—Ramipril—type 2 diabetes mellitus	7.04e-05	0.000343	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—HIF1A—type 2 diabetes mellitus	7.02e-05	0.000813	CbGpPWpGaD
Levetiracetam—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.98e-05	0.00034	CcSEcCtD
Levetiracetam—Nausea—Orlistat—type 2 diabetes mellitus	6.97e-05	0.000339	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	6.9e-05	0.000798	CbGpPWpGaD
Levetiracetam—SV2A—Disease—AKT2—type 2 diabetes mellitus	6.89e-05	0.000798	CbGpPWpGaD
Levetiracetam—Asthenia—Losartan—type 2 diabetes mellitus	6.89e-05	0.000335	CcSEcCtD
Levetiracetam—Vomiting—Metformin—type 2 diabetes mellitus	6.87e-05	0.000334	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—LEP—type 2 diabetes mellitus	6.86e-05	0.000794	CbGpPWpGaD
Levetiracetam—Rash—Metformin—type 2 diabetes mellitus	6.82e-05	0.000332	CcSEcCtD
Levetiracetam—Dermatitis—Metformin—type 2 diabetes mellitus	6.81e-05	0.000331	CcSEcCtD
Levetiracetam—Pruritus—Losartan—type 2 diabetes mellitus	6.79e-05	0.000331	CcSEcCtD
Levetiracetam—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.79e-05	0.00033	CcSEcCtD
Levetiracetam—Headache—Metformin—type 2 diabetes mellitus	6.77e-05	0.00033	CcSEcCtD
Levetiracetam—Dizziness—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000328	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	6.73e-05	0.00078	CbGpPWpGaD
Levetiracetam—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.73e-05	0.000328	CcSEcCtD
Levetiracetam—Diarrhoea—Losartan—type 2 diabetes mellitus	6.57e-05	0.00032	CcSEcCtD
Levetiracetam—SV2A—Disease—SERPINE1—type 2 diabetes mellitus	6.55e-05	0.000758	CbGpPWpGaD
Levetiracetam—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000317	CcSEcCtD
Levetiracetam—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000317	CcSEcCtD
Levetiracetam—Vomiting—Irbesartan—type 2 diabetes mellitus	6.49e-05	0.000316	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—FAS—type 2 diabetes mellitus	6.47e-05	0.000749	CbGpPWpGaD
Levetiracetam—Rash—Irbesartan—type 2 diabetes mellitus	6.43e-05	0.000313	CcSEcCtD
Levetiracetam—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.43e-05	0.000313	CcSEcCtD
Levetiracetam—Nausea—Metformin—type 2 diabetes mellitus	6.42e-05	0.000312	CcSEcCtD
Levetiracetam—Headache—Irbesartan—type 2 diabetes mellitus	6.39e-05	0.000311	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—NOS2—type 2 diabetes mellitus	6.39e-05	0.00074	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—C3—type 2 diabetes mellitus	6.38e-05	0.000738	CbGpPWpGaD
Levetiracetam—Dizziness—Losartan—type 2 diabetes mellitus	6.35e-05	0.000309	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	6.31e-05	0.00073	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOS3—type 2 diabetes mellitus	6.25e-05	0.000724	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIK3R1—type 2 diabetes mellitus	6.25e-05	0.000724	CbGpPWpGaD
Levetiracetam—Vomiting—Losartan—type 2 diabetes mellitus	6.11e-05	0.000297	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	6.09e-05	0.000705	CbGpPWpGaD
Levetiracetam—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.07e-05	0.000295	CcSEcCtD
Levetiracetam—Nausea—Irbesartan—type 2 diabetes mellitus	6.06e-05	0.000295	CcSEcCtD
Levetiracetam—Rash—Losartan—type 2 diabetes mellitus	6.05e-05	0.000295	CcSEcCtD
Levetiracetam—Dermatitis—Losartan—type 2 diabetes mellitus	6.05e-05	0.000294	CcSEcCtD
Levetiracetam—Headache—Losartan—type 2 diabetes mellitus	6.02e-05	0.000293	CcSEcCtD
Levetiracetam—Asthenia—Ramipril—type 2 diabetes mellitus	5.91e-05	0.000287	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—type 2 diabetes mellitus	5.88e-05	0.000681	CbGpPWpGaD
Levetiracetam—Pruritus—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000283	CcSEcCtD
Levetiracetam—SV2A—Disease—PTGS2—type 2 diabetes mellitus	5.72e-05	0.000662	CbGpPWpGaD
Levetiracetam—Nausea—Losartan—type 2 diabetes mellitus	5.7e-05	0.000278	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—type 2 diabetes mellitus	5.69e-05	0.000659	CbGpPWpGaD
Levetiracetam—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000274	CcSEcCtD
Levetiracetam—Dizziness—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000265	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—type 2 diabetes mellitus	5.38e-05	0.000623	CbGpPWpGaD
Levetiracetam—Vomiting—Ramipril—type 2 diabetes mellitus	5.24e-05	0.000255	CcSEcCtD
Levetiracetam—Rash—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000253	CcSEcCtD
Levetiracetam—Dermatitis—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000252	CcSEcCtD
Levetiracetam—Headache—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000251	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	5.07e-05	0.000587	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CASP8—type 2 diabetes mellitus	4.99e-05	0.000578	CbGpPWpGaD
Levetiracetam—Nausea—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000238	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	4.84e-05	0.00056	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	4.84e-05	0.00056	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	4.72e-05	0.000547	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	4.7e-05	0.000543	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	4.67e-05	0.00054	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—type 2 diabetes mellitus	4.65e-05	0.000538	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SRC—type 2 diabetes mellitus	4.63e-05	0.000535	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	4.6e-05	0.000533	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	4.44e-05	0.000514	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	4.44e-05	0.000514	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TGFB1—type 2 diabetes mellitus	4.14e-05	0.000479	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	4.11e-05	0.000476	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—AR—type 2 diabetes mellitus	4.08e-05	0.000472	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	4.06e-05	0.00047	CbGpPWpGaD
Levetiracetam—SV2A—Disease—EGFR—type 2 diabetes mellitus	4.05e-05	0.000469	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.92e-05	0.000454	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—TGFB1—type 2 diabetes mellitus	3.83e-05	0.000443	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CASP3—type 2 diabetes mellitus	3.78e-05	0.000437	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.76e-05	0.000436	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	3.76e-05	0.000435	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	3.72e-05	0.00043	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—type 2 diabetes mellitus	3.7e-05	0.000428	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	3.62e-05	0.000419	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	3.62e-05	0.000419	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	3.49e-05	0.000404	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	3.49e-05	0.000404	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	3.43e-05	0.000397	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.24e-05	0.000375	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.23e-05	0.000374	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—VEGFA—type 2 diabetes mellitus	3.21e-05	0.000371	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.2e-05	0.00037	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	3.19e-05	0.00037	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	3.17e-05	0.000367	CbGpPWpGaD
Levetiracetam—SV2A—Disease—IL6—type 2 diabetes mellitus	3.12e-05	0.000361	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.09e-05	0.000358	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	2.97e-05	0.000343	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—BHMT—type 2 diabetes mellitus	2.95e-05	0.000342	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TGFB1—type 2 diabetes mellitus	2.94e-05	0.000341	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.89e-05	0.000335	CbGpPWpGaD
Levetiracetam—SV2A—Disease—AKT1—type 2 diabetes mellitus	2.87e-05	0.000333	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	2.86e-05	0.000331	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TNF—type 2 diabetes mellitus	2.75e-05	0.000318	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	2.75e-05	0.000318	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.61e-05	0.000302	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGDS—type 2 diabetes mellitus	2.58e-05	0.000299	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AANAT—type 2 diabetes mellitus	2.58e-05	0.000299	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	2.46e-05	0.000285	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CDO1—type 2 diabetes mellitus	2.45e-05	0.000283	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GPD2—type 2 diabetes mellitus	2.45e-05	0.000283	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.45e-05	0.000283	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	2.42e-05	0.00028	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	2.38e-05	0.000276	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—AKT1—type 2 diabetes mellitus	2.36e-05	0.000273	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AK1—type 2 diabetes mellitus	2.34e-05	0.00027	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.27e-05	0.000263	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.27e-05	0.000263	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.22e-05	0.000257	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.21e-05	0.000256	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.19e-05	0.000254	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	2.16e-05	0.000249	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	2.16e-05	0.000249	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	2.11e-05	0.000245	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.08e-05	0.000241	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	2.08e-05	0.000241	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	2.08e-05	0.000241	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	2.08e-05	0.000241	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	2.08e-05	0.000241	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	2.02e-05	0.000233	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	2.01e-05	0.000232	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.94e-05	0.000224	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.93e-05	0.000224	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	1.9e-05	0.00022	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	1.9e-05	0.00022	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	1.86e-05	0.000216	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	1.86e-05	0.000215	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.85e-05	0.000214	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	1.77e-05	0.000205	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	1.77e-05	0.000205	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	1.77e-05	0.000205	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.77e-05	0.000205	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.74e-05	0.000202	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	1.7e-05	0.000196	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	1.7e-05	0.000196	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	1.63e-05	0.000189	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.63e-05	0.000189	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.62e-05	0.000188	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	1.6e-05	0.000186	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.58e-05	0.000183	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.58e-05	0.000183	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	1.58e-05	0.000183	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	1.58e-05	0.000183	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.52e-05	0.000176	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.52e-05	0.000176	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.5e-05	0.000174	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	1.48e-05	0.000172	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.45e-05	0.000168	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.45e-05	0.000168	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.42e-05	0.000165	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.39e-05	0.000161	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.36e-05	0.000157	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.36e-05	0.000157	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.34e-05	0.000155	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.34e-05	0.000155	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.34e-05	0.000155	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.34e-05	0.000155	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.29e-05	0.000149	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.23e-05	0.000142	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.2e-05	0.000138	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.15e-05	0.000133	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.12e-05	0.000129	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.09e-05	0.000127	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.09e-05	0.000127	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.07e-05	0.000124	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.07e-05	0.000123	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.07e-05	0.000123	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.07e-05	0.000123	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.06e-05	0.000123	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.04e-05	0.00012	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.03e-05	0.000119	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.01e-05	0.000117	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	9.56e-06	0.000111	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	9.56e-06	0.000111	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	9.56e-06	0.000111	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	9.38e-06	0.000109	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	9.3e-06	0.000108	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	9.11e-06	0.000105	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	9.1e-06	0.000105	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	8.74e-06	0.000101	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	8.64e-06	0.0001	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	8.64e-06	0.0001	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	8.43e-06	9.76e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	8.29e-06	9.59e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	8.29e-06	9.59e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.14e-06	8.27e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	7.14e-06	8.27e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	7.11e-06	8.23e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	7.01e-06	8.12e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	6.81e-06	7.88e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	6.62e-06	7.67e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	6.5e-06	7.53e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	6.37e-06	7.37e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	6.34e-06	7.34e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	6.18e-06	7.15e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.1e-06	7.06e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	5.85e-06	6.78e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	5.74e-06	6.65e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	5.56e-06	6.44e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	5.47e-06	6.33e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	5.45e-06	6.31e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	5.39e-06	6.24e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	4.75e-06	5.49e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—INS—type 2 diabetes mellitus	4.66e-06	5.39e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	4.27e-06	4.94e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	4.08e-06	4.73e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.08e-06	4.73e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.73e-06	4.32e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.88e-06	2.17e-05	CbGpPWpGaD
